Genomic Press launches an innovative model in scientific publishing that emphasizes academic integrity over profitability. Our mission is to support and empower scientists, educators, and readers. We are committed to fair pricing, ensuring that quality scientific work remains accessible and that knowledge thrives without financial barriers.

Genomic Psychiatry operates on an Article Processing Charge (APC) business model, with all revenue generated through these publication fees. Our APC structure provides the financial foundation for our high-quality peer review, production, and publication processes while maintaining our Open Access status.

From 1 May 2025 to 31 December 2025, Brain Medicine offers promotional global APC rates: €1000/500 for submissions from within the European Union, £860/430 for those from the United Kingdom, CHF 1000/500 for those from Switzerland, JP¥170,000/85,000 for Japanese entries, and USD$990/495 for the United States and all other international submissions, with applicable local taxes. We will reassess our APC structure in 2026. 

The academic and scholarly event announcements from non-profit organizations that appear in our journal are either provided at cost or offered free of charge as a service to the academic community. These announcements do not constitute a significant revenue source and are primarily included as a service to our readership.